2015•Lung CancerRequires access
I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib
Sai‐Hong Ignatius Ou, Joel Greenbowe, Ziad U. Khan, Michele C. Azada, Jeffrey S. Ross, Phil J. Stevens, Siraj M. Ali, Vincent A. Miller, Barbara J. Gitlitz
Open publisher page 81 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.